Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Peloton Interactive Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B), while Peloton Interactive Inc trades at $5.06 (market cap $2.16B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 5.8× Peloton Interactive Inc's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Peloton Interactive Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Peloton Interactive Inc for 37 Days on average.
| HALO | PTON | |
|---|---|---|
Market Cap | $12.58B | $2.16B |
Volume | 2,179,278 | 11,369,487 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $7.86 |
52-Week Low | $61.63 | $3.71 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $14.49B | $2.66B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Peloton (PTON) trades at $5.06, up 4.33% on the day, but remains in a bearish technical trend. The company reported its first full-year net profit in fiscal 2026, with Q2 2026 EPS beating expectations at $0.13 versus $0.12, though revenue declined to $2.49B in 2025. Recent news highlights the launch of a new, more affordable Tread Flex treadmill and AI-powered coaching features as part of its turnaround strategy. Analyst consensus is a 'Buy' with a $8.00 price target, but negative shareholder equity and high debt levels pose significant risks.
The outlook is mixed; cost-cutting and new product launches support a path to sustained profitability, but subscriber declines, high leverage, and insider selling temper optimism. The stock offers speculative upside if execution improves, yet remains vulnerable to competitive pressures and macroeconomic headwinds. Investors should weigh the potential for operational turnaround against persistent financial and business model challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
